KRON — Kronos Bio Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMicro CapNeutral

Annual balance sheet for Kronos Bio, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	413	340	238	173	112
Net Total Accounts Receivable
Net Total Receivables	0.612	0.816	0.572	—	—
Prepaid Expenses
Total Current Assets	420	348	244	179	115
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	41	41.8	37.7	29.9	7
Long Term Investments
Other Long Term Assets
Total Assets	512	391	295	213	124
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	12.9	13.6	21.5	24.7	15.3
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	46.4	46.4	50.4	54.2	36.8
Redeemable Preferred Stock
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	466	345	244	159	87.6
Total Liabilities & Shareholders' Equity	512	391	295	213	124
Total Common Shares Outstanding